Last reviewed · How we verify
MEBO Wound Ointment (MEBO)
MEBO Wound Ointment promotes wound healing by creating a moist healing environment and stimulating tissue regeneration and epithelialization.
MEBO Wound Ointment promotes wound healing by creating a moist healing environment and stimulating tissue regeneration and epithelialization. Used for Burn wounds, Chronic wounds, Wound healing acceleration.
At a glance
| Generic name | MEBO Wound Ointment (MEBO) |
|---|---|
| Also known as | MEBO |
| Sponsor | Skingenix, Inc. |
| Drug class | Topical wound healing agent |
| Modality | Small molecule |
| Therapeutic area | Dermatology / Wound Care |
| Phase | Phase 3 |
Mechanism of action
MEBO is a topical ointment formulation containing a blend of oils and botanical extracts designed to maintain optimal moisture at the wound site while promoting angiogenesis and collagen deposition. The formulation is intended to accelerate the natural healing process by supporting the proliferative and remodeling phases of wound repair, particularly in burn wounds and chronic wounds.
Approved indications
- Burn wounds
- Chronic wounds
- Wound healing acceleration
Common side effects
- Local irritation or sensitization
- Allergic contact dermatitis
Key clinical trials
- A Clinical Study of the Safety and Efficacy of MEBO® Wound Ointment in Subjects With Diabetic Foot Ulcers (Pilot) (PHASE2)
- A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Venous Leg Ulcers (PHASE2)
- A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Diabetic Foot Ulcers (PHASE2)
- Zinc Oxide VS MEBO (PHASE4)
- A Prospective Study on the Therapeutic Outcomes of Mebo and Tantum Verde in Patients With Oral Mucositis (PHASE3)
- Comparative Evaluation of MEBO Ointment and Topical Diltiazem Ointment in the Treatment of Acute Anal Fissure (PHASE2)
- Effect of Mebo Dressing Versus Standard Care on Managing Donor and Recipient Sites of Split-thickness Skin Graft (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- MEBO Wound Ointment (MEBO) CI brief — competitive landscape report
- MEBO Wound Ointment (MEBO) updates RSS · CI watch RSS
- Skingenix, Inc. portfolio CI